TickerFactsScreenerDevelopers

LIGAND PHARMACEUTICALS INC (LGND) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: -$10.37M2009: $3.74M2010: -$4.85M2011: $8.19M2012: $26.48M2013: $49.61M2014: $26.32M2015: $237.28M2016: $341.29M2017: $399.79M2018: $560.91M2019: $767.23M2020: $709.52M2021: $821.16M2022: $597.49M2023: $700.91M2024: $830.44M2025: $1.02B$1.02B
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.02B+22.5%
2024$830.44M+18.5%
2023$700.91M+17.3%
2022$597.49M-27.2%
2021$821.16M+15.7%
2020$709.52M-7.5%
2019$767.23M+36.8%
2018$560.91M+40.3%
2017$399.79M+17.1%
2016$341.29M+43.8%
2015$237.28M+801.6%
2014$26.32M-47.0%
2013$49.61M+87.3%
2012$26.48M+223.6%
2011$8.19M+268.8%
2010-$4.85M-229.5%
2009$3.74M+136.1%
2008-$10.37M—